Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.

ABSTRACT:

Importance

Current guidelines support treating atrial fibrillation (AF) and atrial flutter (AFL) as equivalent risk factors for ischemic stroke stratified by CHA2DS2-VASc scores, recommending anticoagulation therapy for patients with a CHA2DS2-VASc score of 2 or higher, but some studies found differences in clinical outcomes.

Objective

To investigate differences in clinical outcomes among AF, AFL, and matched control cohorts.

Design, setting, and participants

This nationwide cohort study analyzed data from the Taiwan National Health Insurance Research Database from January 1, 2001, through December 31, 2012. Follow-up and data analysis ended December 31, 2012. A total of 219 416 age- and sex-matched individuals participated in the study. Clinical outcomes were compare

SUBMITTER: Lin YS 

PROVIDER: S-EPMC6324304 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature